Physician profile
Bin Jiang
NPI 1447982491
$691.49
in general payments reported to CMS, 2019-2025
8 companies · $33.70 in 2025
The $33.70 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $229 · 2023: $302 · 2024: $127 · 2025: $33.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $206.97 | 2023-2024 | |
| Gilead Sciences, INC. | $118.11 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $95.44 | 2022 | |
| Mallinckrodt Hospital Products INC. | $83.20 | 2023 | Acthar |
| Alexion Pharmaceuticals, INC. | $54.03 | 2024-2025 | Ultomiris |
| Janssen Biotech, INC. | $49.30 | 2023-2024 | Tecvayli, Darzalex, Carvykti |
| Janssen Pharmaceuticals, INC | $47.81 | 2022-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.63 | 2024-2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bin Jiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.